Showing results (161-170 of 187) with videos related to

Sort By:
Pageof 19
International Journal of STD & AIDS|May 17, 2008
Treatment outcome and cost-effectiveness of different highly active antiretroviral therapy regimens in the UK (1996-2002)E J Beck, S Mandalia, M Youle, et al.
HIV Medicine|April 17, 2014
A comparison of computational models with and without genotyping for prediction of response to second-line HIV therapyA D Revell, M A Boyd, D Wang, et al.
British Journal of Cancer|April 15, 2004
Outcome of patients with HIV-related germ cell tumours: a case-control studyT Powles, M Bower, J Shamash, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2013
The immunomodulatory nutritional intervention NR100157 reduced CD4+ T-cell decline and immune activation: a 1-year multicenter randomized controlled double-blind trial in HIV-infected persons not receiving antiretroviral therapy (The BITE Study)P Cahn, K Ruxrungtham, B Gazzard, et al.
HIV Medicine|December 12, 2001
A randomized, double-blind, placebo-controlled study of itraconazole capsules for the prevention of deep fungal infections in immunodeficient patients with HIV infectionD E Smith, J Bell, M Johnson, et al.
HIV Medicine|March 12, 2004
Evidence of thymic reconstitution after highly active antiretroviral therapy in HIV-1 infectionG Hardy, S Worrell, P Hayes, et al.
AIDS Care|July 23, 2013
Screening for HIV-related neurocognitive impairment in clinical practice: challenges and opportunitiesT J Barber, D Bradshaw, D Hughes, et al.
Journal of Viral Hepatitis|October 21, 2009
The prevalence of hepatitis C virus (HCV) infection in HIV-positive individuals in the UK - trends in HCV testing and the impact of HCV on HIV treatment outcomesJ Turner, L Bansi, R Gilson, et al.
HIV Medicine|January 18, 2008
Patterns and predictors of the use of different antiretroviral drug regimens at treatment initiation in the UKP J Easterbrook, A N Phillips, T Hill, et al.
The Journal of Infectious Diseases|June 9, 2001
The steady-state pharmacokinetics of efavirenz and nevirapine when used in combination in human immunodeficiency virus type 1-infected personsA I Veldkamp, M Harris, J S Montaner, et al.
Pageof 19